Your browser doesn't support javascript.
loading
SDF-1 inhibition targets the bone marrow niche for cancer therapy.
Roccaro, Aldo M; Sacco, Antonio; Purschke, Werner G; Moschetta, Michele; Buchner, Klaus; Maasch, Christian; Zboralski, Dirk; Zöllner, Stefan; Vonhoff, Stefan; Mishima, Yuji; Maiso, Patricia; Reagan, Michaela R; Lonardi, Silvia; Ungari, Marco; Facchetti, Fabio; Eulberg, Dirk; Kruschinski, Anna; Vater, Axel; Rossi, Giuseppe; Klussmann, Sven; Ghobrial, Irene M.
Afiliación
  • Roccaro AM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Sacco A; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Purschke WG; NOXXON Pharma AG, 10589 Berlin, Germany.
  • Moschetta M; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Buchner K; NOXXON Pharma AG, 10589 Berlin, Germany.
  • Maasch C; NOXXON Pharma AG, 10589 Berlin, Germany.
  • Zboralski D; NOXXON Pharma AG, 10589 Berlin, Germany.
  • Zöllner S; NOXXON Pharma AG, 10589 Berlin, Germany.
  • Vonhoff S; NOXXON Pharma AG, 10589 Berlin, Germany.
  • Mishima Y; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Maiso P; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Reagan MR; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA.
  • Lonardi S; Department of Pathology, University of Brescia Medical School, Spedali Civili di Brescia, 25123 Brescia, Italy.
  • Ungari M; Department of Pathology, University of Brescia Medical School, Spedali Civili di Brescia, 25123 Brescia, Italy.
  • Facchetti F; Department of Pathology, University of Brescia Medical School, Spedali Civili di Brescia, 25123 Brescia, Italy.
  • Eulberg D; NOXXON Pharma AG, 10589 Berlin, Germany.
  • Kruschinski A; NOXXON Pharma AG, 10589 Berlin, Germany.
  • Vater A; NOXXON Pharma AG, 10589 Berlin, Germany.
  • Rossi G; Spedali Civili di Brescia, Department of Hematology, Centro per la Ricerca Onco-ematologica AIL, (CREA), 25123 Brescia, Italy.
  • Klussmann S; NOXXON Pharma AG, 10589 Berlin, Germany.
  • Ghobrial IM; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. Electronic address: irene_ghobrial@dfci.harvard.edu.
Cell Rep ; 9(1): 118-128, 2014 Oct 09.
Article en En | MEDLINE | ID: mdl-25263552
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligonucleótidos / Médula Ósea / Quimiocina CXCL12 / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Cell Rep Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Oligonucleótidos / Médula Ósea / Quimiocina CXCL12 / Mieloma Múltiple Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans / Male Idioma: En Revista: Cell Rep Año: 2014 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos